Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Free Subscription


1 Acta Haematol
1 Am J Clin Oncol
2 Am J Clin Pathol
2 Ann Hematol
1 Blood
2 Bone Marrow Transplant
6 Br J Haematol
1 Cancer
1 Eur J Haematol
1 Exp Cell Res
1 Exp Hematol
1 Gene
1 Genes Chromosomes Cancer
1 Int J Hematol
5 Leuk Lymphoma
1 Leuk Res
4 Leukemia
1 Nat Rev Cancer
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Haematol

  1. WAHNSCHAFFE L, Herling M
    What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 May 5:1-3. doi: 10.1159/000507415.

    Am J Clin Oncol

    Vincristine Shortage: What Other Options We Have?
    Am J Clin Oncol. 2020;43:146-147.

    Am J Clin Pathol

  3. MIZUTA S, Yamane N, Mononobe S, Komai T, et al
    cDNA-Based Mutation Screening Using a Combination of High-Resolution Melting Curve and Fragment Analysis Facilitates Efficient CCR4 Mutation Analysis in Adult T-Cell Leukemia/Lymphoma.
    Am J Clin Pathol. 2020 May 5. pii: 5829725. doi: 10.1093.
    PubMed         Abstract available

  4. DALLAND JC, Meyer R, Ketterling RP, Reichard KK, et al
    Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
    Am J Clin Pathol. 2020;153:333-341.
    PubMed         Abstract available

    Ann Hematol

  5. YANADA M, Takami A, Yamasaki S, Arai Y, et al
    Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century.
    Ann Hematol. 2020 May 4. pii: 10.1007/s00277-020-04051.
    PubMed         Abstract available

  6. MAAKARON JE, Ozga MP, Mannis GN, Pulley W, et al
    Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia.
    Ann Hematol. 2020 May 6. pii: 10.1007/s00277-020-04054.


  7. YANG M, Safavi S, Woodward EL, Duployez N, et al
    13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
    Blood. 2020 May 8. pii: 454973. doi: 10.1182/blood.2019004684.
    PubMed         Abstract available

    Bone Marrow Transplant

  8. PERIC Z, Labopin M, Peczynski C, Polge E, et al
    Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT.
    Bone Marrow Transplant. 2020 May 2. pii: 10.1038/s41409-020-0878.
    PubMed         Abstract available

  9. COOPERRIDER JH, Fulton N, Artz AS, Larson RA, et al
    Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2020 May 6. pii: 10.1038/s41409-020-0925.

    Br J Haematol

  10. BATALLER A, Combalia A, Garcia-Herrera A, Estrach T, et al
    Isolated cutaneous lymphomatous form of adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2019 Jan 6. doi: 10.1111/bjh.15744.

  11. MIYAMURA T, Moritake H, Nakayama H, Tanaka S, et al
    Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
    Br J Haematol. 2019 Feb 19. doi: 10.1111/bjh.15799.
    PubMed         Abstract available

  12. BURKHARDT B, Hermiston ML
    Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
    Br J Haematol. 2019 Feb 27. doi: 10.1111/bjh.15793.
    PubMed         Abstract available

  13. BALDACINI M, Pop R, Sattler L, Mauvieux L, et al
    Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia.
    Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16768.
    PubMed         Abstract available

  14. WU Y, Lin H, Xie Q, Chen Q, et al
    COVID-19 in a patient with pre-existing acute lymphoblastic leukemia.
    Br J Haematol. 2020 May 7. doi: 10.1111/bjh.16799.
    PubMed         Abstract available

  15. AILAWADHI S, Dholaria BR, Khurana S, Sher T, et al
    Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma.
    Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15458.


  16. GILL HS, Yim R, Kumana CR, Tse E, et al
    Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.
    Cancer. 2020 May 4. doi: 10.1002/cncr.32937.
    PubMed         Abstract available

    Eur J Haematol

  17. CESINI L, Frieri C, Barate C, Sora F, et al
    Erythropoietin Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Frontline Imatinib who Developed Late Anemia.
    Eur J Haematol. 2020 May 4. doi: 10.1111/ejh.13436.
    PubMed         Abstract available

    Exp Cell Res

  18. CHEN C, Wang L, Li L, Wang A, et al
    Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.
    Exp Cell Res. 2020 May 3:112054. doi: 10.1016/j.yexcr.2020.112054.
    PubMed         Abstract available

    Exp Hematol

  19. PAGLIARO S, Desterke C, Acloque H, Chomel JC, et al
    Exp Hematol. 2020 Apr 28. pii: S0301-472X(20)30142.
    PubMed         Abstract available


  20. LIU X, Zhou C, Li Y, Deng Y, et al
    Upregulation of circ-0000745 in acute lymphoblastic leukemia enhanced cerll proliferation by activating ERK pathway.
    Gene. 2020 Apr 30:144726. doi: 10.1016/j.gene.2020.144726.
    PubMed         Abstract available

    Genes Chromosomes Cancer

  21. OHKI K, Takahashi H, Fukushima T, Nanmoku T, et al
    Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
    Genes Chromosomes Cancer. 2020 May 5. doi: 10.1002/gcc.22858.
    PubMed         Abstract available

    Int J Hematol

  22. YOSHINO H, Nishiyama Y, Kamma H, Chiba T, et al
    Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood.
    Int J Hematol. 2020 May 4. pii: 10.1007/s12185-020-02885.
    PubMed         Abstract available

    Leuk Lymphoma

  23. LUSKIN MR, Kim AS, Patel SS, Wright K, et al
    Evidence for separate transformation to acute myeloid leukemia and blastic plamacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone.
    Leuk Lymphoma. 2020 May 4:1-4. doi: 10.1080/10428194.2020.1755856.

  24. BEWERSDORF JP, Shallis RM, Gowda L, Wei W, et al
    Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience.
    Leuk Lymphoma. 2020 May 2:1-11. doi: 10.1080/10428194.2020.1759051.
    PubMed         Abstract available

  25. JABBOUR E, Stelljes M, Advani AS, DeAngelo DJ, et al
    Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database.
    Leuk Lymphoma. 2020 May 7:1-4. doi: 10.1080/10428194.2020.1751839.

  26. HAN H, Shin DY, Kim D, Kim H, et al
    Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia.
    Leuk Lymphoma. 2020 May 6:1-11. doi: 10.1080/10428194.2020.1747062.
    PubMed         Abstract available

  27. TODISCO E, Gigli F, Sammassimo S, Camisaschi C, et al
    Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.
    Leuk Lymphoma. 2020 May 2:1-3. doi: 10.1080/10428194.2020.1759049.

    Leuk Res

  28. CIANGOLA G, Gurnari C, Paterno G, Mirabile M, et al
    Corrigendum to "STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype" [Leuk. Res. 78 (2019) 21-23].
    Leuk Res. 2020 May 4:106148. doi: 10.1016/j.leukres.2019.


  29. GARCIA-CANAVERAS JC, Lancho O, Ducker GS, Ghergurovich JM, et al
    SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia.
    Leukemia. 2020 May 7. pii: 10.1038/s41375-020-0845.
    PubMed         Abstract available

  30. HOCHHAUS A, Breccia M, Saglio G, Garcia-Gutierrez V, et al
    Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors.
    Leukemia. 2020 May 4. pii: 10.1038/s41375-020-0842.
    PubMed         Abstract available

  31. JOSHI SK, Keck JM, Eide CA, Bottomly D, et al
    ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.
    Leukemia. 2020 May 4. pii: 10.1038/s41375-020-0844.

  32. BAMOPOULOS SA, Batcha AMN, Jurinovic V, Rothenberg-Thurley M, et al
    Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
    Leukemia. 2020 May 1. pii: 10.1038/s41375-020-0839.
    PubMed         Abstract available

    Nat Rev Cancer

  33. VETRIE D, Helgason GV, Copland M
    The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML.
    Nat Rev Cancer. 2020 Jan 6. pii: 10.1038/s41568-019-0230.
    PubMed         Abstract available

    PLoS One

  34. SOK P, Lupo PJ, Richard MA, Rabin KR, et al
    Utilization of archived neonatal dried blood spots for genome-wide genotyping.
    PLoS One. 2020;15:e0229352.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.